Why the study?
The impact of myocardial infarction is shifting toward adverse remodeling and chronic left ventricular dysfunction, warranting non-invasive circulating biomarkers for risk stratification.
Do circulating biomarkers predict left ventricular remodeling in patients after myocardial infarction?
Do circulating biomarkers predict left ventricular remodeling in patients after myocardial infarction?
While many circulating biomarkers correlate with post-MI left ventricular remodeling, a combination of biomarkers from different pathophysiological pathways may be necessary for accurate prediction.
No takes yet. Share an insight, caveat, or question.
Many biomarkers correlate with post-MI remodeling yet many do not; leaves open whether multi-pathway panels improve prediction.
Węgiel et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: